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ABSTRACT
Objectives The sympathetic nervous system (SNS) as
well as the interleukin (IL)-7/IL-7 receptor (IL-7R) system
play a role in the pathogenesis of arthritis. However, the
target cells and mechanisms involved are not fully
resolved. The goal of this study was to determine if
B cells are inﬂuenced by IL-7 and to investigate the
possible interplay between the SNS and the IL-7/IL-7R
system on B cells in arthritis.
Methods Collagen type II-induced arthritis (CIA) in DBA1
mice. ELISA to determine speciﬁc anti-CII antibodies.
Fluorescence activated cell sorting (FACS) analysis to
determine IL-7R+ cells and intracellular phosphorylated
signal transducer and activator of transcription 5 (pSTAT5).
Immunohistochemistry to show IL-7R+ B cells in rheumatoid
arthritis (RA) and osteoarthritis (OA) synovial tissue.
Results IL-7 stimulated IL-7R+ mature B cells act
proinﬂammatory (increased clinical score, increased
anticollagen type II antibodies) after cell transfer in CIA.
The sympathetic neurotransmitter norepinephrine abrogates
this effect. Expression of IL-7Rα is increased when B cells
are activated (anti-CD40 or lipopolysaccharide) in vitro and
stimulating the IL-7R induces intracellular accumulation of
pSTAT5. α- And β-adrenergic agonists show no inﬂuence
on expression levels of IL-7R on activated B cells; however,
intracellular IL-7R downstream signalling is abrogated via
the β2-adreonceptor (β2AR) agonist terbutaline. IL-7R and
β2AR are also expressed on B cells in synovial tissue from
RA and OA patients.
Conclusions These data indicate that IL7R+ B cells have
a proinﬂammatory role in arthritis which can be inhibited
by the sympathetic neurotransmitter norepinephrine via
inhibition of IL-7R signalling.
INTRODUCTION
Interleukin (IL)-7 is a cytokine involved in the regu-
lation of B cell development and survival.1 2 In later
stages of B cell development, the role played by IL-7
is more controversial and reports showing expres-
sion of the receptor on mature B cells are scarce.3–6
The IL-7 receptor (IL-7R) is heterodimeric, con-
sisting of IL-7Rα chain (IL-7Rα, CD127) and the
common γ chain;7 the latter is also a component of
the IL-2-, IL-4-, IL-9-, IL-15- and IL-21 receptor.8
Dimerisation of the IL-7Rα chain and the common
γ chain mainly activates a signal transducer and
activator of transcription 5 (STAT 5)-dependent
pathways via Janus kinase 1 and 3 (reviewed in9).
In arthritis, IL-7 might play an important role10
since IL-7 in synovial ﬂuid and serum from
rheumatoid arthritis (RA) patients was detected at a
higher level as compared with osteoarthritis (OA)
patients and correlated in serum with C reactive
protein.11 12 IL-7 is produced in RA synovium13 14 by
ﬁbroblast-like synoviocytes15 macrophages, ﬁbro-
blasts, endothelial cells11 and nurse-like synovial cells
that express costimulatory molecules, and is capable
of rescuing B cells from apoptosis.15 16 Furthermore,
IL-7/IL-7R pathway-related genes were increased in
RA synovial tissue containing ectopic lymphoid struc-
tures with local activation of B cells.17 Mice treated
with IL-7 during collagen type II-induced arthritis
(CIA) showed an expansion of the B and T cell pool
and increased joint destruction.18 Expression of
IL-7R on CD19 B cells, CD4 Tcells and CD14 mono-
cytes in RA synovial tissue was reported recently and
therapeutic blockade of IL-7 signalling in RA or CIA
has therapeutic potential by inhibiting T cells.
Recently, it has been shown that RA ﬁbroblasts and to
a lesser extent CD4 T cells, in contrast to CD8 Tand
B cells, express a soluble form of the IL-7R, which
can counteract the action of IL-7 in the inﬂamed
synovium.6
The sympathetic nervous system (SNS) modulates
both arthritis severity19 20 and B cell function.21 22
The SNS supports inﬂammation in the initiation phase
and suppresses inﬂammation in the late phase of
CIA.19 23 The proinﬂammatory effect during the initi-
ation phase might be mediated via promoting T
cells.23 24 In the late phase of CIA the SNS increases
IL-10 production and anti-inﬂammatory properties of
B cells20 in addition to the occurrence of possible anti-
inﬂammatory catecholamine-producing cells.25 26 The
inﬂuence of the SNS on B cells during initiation of
arthritis is less clear. It has been shown in several
reports that B cell response following T-dependent
antigens is impaired in the absence of sympathetic
stimuli.21 22 One could speculate that increased
T-dependent antibody production promotes inﬂam-
mation in the initiation phase.
The goals of this study were to determine the
role of the IL-7/IL-7R system on B cells in arthritis
and to investigate the possible interplay between
the SNS and the IL-7/IL-7R system on B cells in the
context of arthritis.
MATERIAL AND METHODS
Animals, induction of arthritis
and arthritis scoring
Male DBA/1 mice (6–8 weeks, Elevage Janvier, Le
Genest St Isle, France) were fed standard chow and
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water ad libitum and kept at a 12 h light–dark cycle.
Experiments were conducted according to institutional and gov-
ernmental regulations for animal use (Government of the
Oberpfalz AZ 54-2531.1-24/06).
Experimental arthritis was induced in DBA/1 mice, as previ-
ously described20 by intradermal injection with 100 mg of
bovine type II collagen (CII, Chondrex, Redmond, Washington,
USA) and Freund’s complete adjuvant (CFA, Sigma). Clinical
scoring points were assigned in a blinded manner as described
previously.27 A score of 0 (no swelling), 1 (light swelling) or 2
(strong swelling) was determined for four toes at each paw, four
paws and ankle/wrist joints with a maximum of 48 points.
Determination of speciﬁc anticollagen type II antibodies
Venous blood was obtained from the tail vein at indicated time
points. Serum samples were stored at −80°C until analysis.
Anticollagen type II antibodies were determined using commercially
available ELISA kits (MD Biosciences GmbH, Zürich, Switzerland).
B cell in vitro culture
Mature splenic B cells were isolated using magnetic bead cell
sorting (MACS, B cell isolation kit, Miltenyi Biotec, Germany).
After isolation, >96% were CD19/CD20 B cells. After resus-
pending in complete RPMI (cRPMI: RPMI 1640, 25 mM
HEPES, pH 7.4, 5% fetal calf serum, 30 mM mercaptoethanol,
0.57 mM ascorbic acid, 100 units/ml penicillin, 100 mg/ml
streptomycin (all from Sigma, Munich, Germany)) containing
anti-CD40 (5 mg/ml, clone: FGK 45.5, Miltenyi Biotec,
Bergisch-Gladbach, Germany) and functional grade IL-4 (1 ng/
ml, eBioscience), cells were cultured in the presence or absence
of norepinephrine, β2-adreonceptor (β2AR) speciﬁc agonist ter-
butaline, α1-speciﬁc agonist phenylephrine, α2-speciﬁc agonist
clonidin or cortisol as indicated.
Treatment of early arthritis mice with cultured B cells
B cells were cultured for 5 days in 6-well plates at 2.5×106/ml in
the presence or absence of norepinephrine. After 5 days, recom-
binant murine IL-7 (R&D Systems, 20 ng/ml) or vehicle was
added to the cells for 30 min. After the incubation, cells were
washed ﬁve times, resuspended in phosphate buffered saline
(PBS) and used for treatment of CIA mice at day 19 (1.5×106 B
cell/100 ml intravenous).
Analysis of IL-7Rα expression on murine B cells
Before and after 5 days of culture, FACS was performed to
determine expression of IL-7Rα (CD127) on CD19 B cells. B
cells were stained with FITC-labelled rat anti-mouse CD19 and
PE-labelled rat antimouse CD127 (Clone A7R34, eBioscience,
Frankfurt, Germany) or respective isotype control for 15 min at
4°C in the dark. Cells were also stained with 7-AAD to exclude
dead cells. FACS analysis was performed on a FACS Calibur
(Becton Dickinson Immunocytometry Systems, San Jose,
California, USA). Data were analysed with FlowJo Software
(V.7.2.4., Tree Star Inc., Oregon, USA).
Intracellular measurement of phosphorylated STAT5
After 5 days of culture, B cells were analysed for the intracellular
amount of pSTAT5 at time point 0, 10 and 30 min following
exposure to IL-7 (20 ng/ml, R&D Systems). Cells were ﬁxed
(1.5% formaldehyde) and permeabilised with methanol accord-
ing to a published method.28 B cells were stained with monoclo-
nal rabbit antiphospho-STAT5A/B (Tyr694/699, Clone: A11W,
Millipore, Schwalbach, Germany) or respective isotype control
for 30 min at 4°C. Biotinylated, polyclonal goat antirabbit IgG
(Dako, Hamburg, Germany) was used as secondary antibody.
FACS was performed after staining with PE-labelled streptavi-
din. Samples were also stained with secondary antibody and
PE-streptavidin only to exclude unspeciﬁc binding.
Immunhistochemical analysis of IL-7Rα+ B cells
in synovial tissue
Synovial tissue from RA and OA patients obtained during knee
replacement surgery was prepared for histological studies as
described.29 All patients gave written consent. The study was
approved by the Ethics Committee of the University of
Regensburg. Cryosections (5 μm) were stained with antibodies
against CD19 (polyclonal, rabbit antihuman CD19, 5 mg/ml, Santa
Cruz, Heidelberg, Germany), IL-7Rα (monoclonal, Clone: 40131,
mouse antihuman CD127, Dilution: 1:100, Sigma-Aldrich GmbH,
Taufkirchen, Germany) or β2AR (polyclonal, rabbit antihuman
β2AR, 1:200, Biozol, Eching, Germany) overnight at 4°C.
Secondary antibodies coupled to AlexaFluor 546 or AlexaFluor
488 (polyclonal, goat vs rabbit, goat vs mouse, or donkey vs rat.
Invitrogen, Karlsruhe, Germany) were applied for 90 min at 21°C.
Slides were blocked with PBS containing 10% fetal bovine serum,
10% bovine serum albumin, and 10% donkey serum, or 10% goat
serum for 45 min at 21°C. After 40-6-diamidino-2-phenylindole
(DAPI; Roche, Mannheim, Germany) staining, slides were covered
with ﬂuorescence mounting medium (DAKO, Hamburg, Germany)
and stored at 4°C until. Control stainings with the primary or sec-
ondary antibody alone or respective isotype controls were negative.
FACS analysis of IL-7Rα+ B cells in synovial tissue
Mixed synoviocytes were isolated from RA and OA tissue as
described before.29 Synoviocytes were stained (15 min, 4°C) with
PE-labelled mouse antihuman CD127 (Clone: hIL-7R-M21, BD
Pharmingen, Heidelberg) and counterstained with FITC-labelled
mouse antihuman CD19 (BD Pharmingen, Heidelberg) or mouse
antihuman CD20 (MACS, Miltenyi Biotec, Bergisch-Gladbach),
respectively. Respective isotype control antibodies were used as a
control for unspeciﬁc binding. Cells were stained with 7-AAD
(BD Pharmingen, Heidelberg) to exclude dead cells.
Statistical analysis
The non-parametric Mann–Whitney test was used to compare
two groups, and ANOVA with post hoc tests was used to
compare multiple groups. All analyses were conducted using
Sigma Plot for Windows (V.11; Systat software Inc). p Values
<0.05 were considered signiﬁcant.
RESULTS
Short term exposure to IL-7 increases proinﬂammatory
action of B cells in CIA
A pathogenetic contribution of the IL-7/IL7Rα system in RA but
also collagen-induced arthritis was suggested before.3 6 17 30 To
determine the role of IL-7Rα expressing B cells in CIA, B cells
were activated with anti-CD40/IL-4 for 5 days and exposed to
IL-7 or vehicle for 30 min before B cells were injected intraven-
ously into DBA1 mice at day 19 after immunisation. Mice
receiving B cells stimulated with IL-7 demonstrated a signiﬁcant
increase in clinical score (ﬁgure 1A, white circles vs white trian-
gles) and anti-CII antibodies (ﬁgure 1B, white circles vs white
triangles) as compared with control.
Norepinephrine inﬂuences IL-7-induced proinﬂammatory
B cell activity
The SNS acts proinﬂammatory during the induction phase of
CIA31 and augments T-dependent B cell responses.21 22 32 To
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determine if norepinephrine further increases the proinﬂamma-
tory potential of IL-7 stimulated B cells, we activated B cells in
the presence of norepinephrine.
Surprisingly, treatment of mice with IL-7 stimulated B cells acti-
vated in the presence of norepinephrine did not result in increased
severity of arthritis (ﬁgure 1A, white circles vs black triangles) and
Figure 1 Proinﬂammatory action of IL-7R+ B cells in collagen type II-induced arthritis (CIA) is diminished by the sympathetic neurotransmitter
norepinephrine. Following in vitro activation of B cells with anti-CD40/IL-4 (BL, white circle, white triangle) in the absence (white symbols) or
presence (black symbols) of norepinephrine (Nor, 10−6 M) and after stimulating the cells with IL-7 (white and black triangles) or PBS (white and
black circles) as indicated, 1.5×106 B cells were transferred intravenously to CIA mice on day 19 postimmunisation (arrow). Clinical score (A) was
recorded and concentration of anti-CII antibodies (Abs) in serum (B) was determined at indicated time points. The symbols represent the mean of
two independent experiments with six animals in each group. ANOVA (general linear model) showed the different treatments as a signiﬁcant source
of variation for clinical score (A, p<0.001) and anti-CII antibody serum concentration (B, p<0.001), respectively. Post hoc analysis (Holm-Sidak)
revealed a signiﬁcant increase as compared with the control group (anti-CD40/IL-4+PBS) for clinical score (A): BL+IL-7 (days 28–61), BL+Nor (days
27–44) and anti-CII Abs serum levels: BL+Nor (p<0.001), BL+IL-7 (p=0.002) and BL+Nor+IL-7 (p=0.026). Error bars represent the SEM. Anti-CII
Abs, anticollagen type II antibodies; i.v., intravenous; p.i., postimmunisation.
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delayed the increase in speciﬁc CII antibody production (ﬁgure
1B, black triangles).
This suggests that the presence of norepinephrine during activa-
tion of B cells renders B cells unresponsive to proinﬂammatory
effects of IL-7. On the contrary, an IL-7 stimulus on B cells pre-
treated with norepinephrine (ﬁgure 1A, black triangles) leads to
anti-inﬂammatory effects, with decreased arthritis severity as com-
pared with treatment with norepinephrine only exposed B cells
(ﬁgure 1A, black circles). Therefore, norepinephrine inhibits and
reverses the proinﬂammatory effect of IL-7 on B cells in CIA.
In vitro culture induces IL-7Rα expression on mature B cells
Since the expression of the IL-7Rα is a prerequisite for B cells
to react to IL-7, we determined whether naive splenic B cells
from DBA1 mice increase IL-7Rα upon activation in vitro.
Isolated naive B cells were cultured for 2 days in the presence
or absence of different B cell activating stimuli (ﬁgure 2A). The
activation of B cells via CD40 independent of IL-4 or INF-γ,
respectively, increased IL-7Rα expression on splenic B cells from
DBA1 mice (ﬁgure 2B). Additionally, lipopolysaccharide, the
activation signal via TLR4, also increased IL-7Rα expression
(ﬁgure 2B). These data conﬁrm increased expression of IL-7R
on B cells activated in vitro.
Figure 2 In vitro activation of splenic naive B cells leads to increased
expression of IL-7 receptor α (IL-7Rα). (A) Representative FACS
histogram showing increased expression of IL-7Rα on B cells activated
in the presence of anti-CD40 and IL-4 for 2 days. Red line: Isotype
control, blue line: IL-7Rα signal. Mean ﬂuorescence intensity (MFI).
(B) Increase of IL–7Rα on B cells activated with different stimuli. Each
dot represents IL-7R MFI on gated CD19+ B cells after subtraction of
the MFI of the respective isotype control. p Value was determined by
ANOVA (overall difference between groups: p=0.015) and post hoc
analysis (Bonferroni). *p<0.05, **p<0.01 as compared with
unstimulated B cells (naive mature). Results are presented as box plots,
horizontal lines represent the median value. IL-4, interleukin-4; INFγ,
interferon-γ; LPS, lipopolysaccharide. N >3.
Figure 3 Adrenergic inﬂuence on IL-7R expression and signalling in
B cells. (A) Each dot represents the mean ﬂuorescence intensity of IL-7R
expressed on B cells activated with anti-CD40/IL-4 (BL) in the presence
or absence of different adrenergic stimuli (β2-adrenoceptor speciﬁc
agonist terbutaline (Terb, 10−6 M), α1-speciﬁc agonist phenylephrine
(5×10−6 M), α2-speciﬁc agonist clonidin (5×10−6 M)) or cortisol
(10−6 M). Results are presented as box plots, horizontal lines represent
the median value. p Values were determined by ANOVA followed by
Bonferroni post hoc analysis. *p<0.05, **p<0.01, ***p<0.001 as
compared with unstimulated B cells (naive B cells). (B) Intracellular
FACS analysis of accumulation of pSTAT5 over time (minutes) following
IL-7 exposure of activated B cells. Error bars represent the SEM. Six
(BL and BL+Terb) and four (BL+Cortisol) independent experiments were
performed. p Values were determined by ANOVA (overall treatment:
p=0.008) and post hoc analysis (Student-Newman-Keuls, BL vs BL+
Terb: p=0.015; BL vs BL+Cort: p=0.012; BL+Terb vs BL+Cort: p=0.457).
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Cortisol but not adrenergic stimuli inhibit activation-induced
IL-7Rα expression on mature B cells
One reason for the dampened IL-7 response following activa-
tion of B cells in the presence of norepinephrine might be a
change in IL-7Rα expression. Therefore, B cells were activated
in the presence of adrenergic stimuli as indicated (ﬁgure 3A).
Additionally, B cells were activated in the presence of cortisol,
according to a report showing an increase of IL-7Rα following
cortisol exposure.5
Neither of the adrenoceptor agonists induced a signiﬁcant
decrease of IL-7Rα expression on B cells as compared with
anti-CD40/IL-4 activated B cells (ﬁgure 3A). Unexpectedly,
expression levels of IL-7Rα on cortisol treated B cells did not
change as compared with naive B cells. These results suggest
that adrenergic stimuli do not inﬂuence and cortisol slightly
inhibits IL-7Rα re-expression on activated B cells.
Activation of B cells in the presence of β2AR agonist
hinders IL-7Rα downstream signalling
Next, the hypothesis was tested whether adrenoceptor stimula-
tion alters phosphorylation of STAT5, which is the major down-
stream signal following IL-7R activation.33 B cells were activated
in the presence or absence of different adrenoceptor agonists or
cortisol, as indicated (ﬁgure 3B).
The generation of pSTAT5 accumulating after IL-7 exposure
was inhibited in activated B cells by pretreatment with the β2AR
agonist terbutaline or cortisol (ﬁgure 3B). Pretreatment with
α-adrenoceptor agonists did not show this inhibition (data not
shown). These data suggest that β2AR stimulation during activa-
tion renders B cells unresponsive to IL-7 due to inhibiting phos-
phorylation of STAT5. The data also show that IL-7R
re-expressed on mature B cells are functional, leading to an
increase in pSTAT5 following IL-7 exposure.
IL-7Rα and β2AR is expressed on B cells in synovial tissue
of RA and OA patients
Immunohistochemistry shows that IL-7Rα is expressed on
CD19+ synovial B cells (ﬁgure 4A). The absolute number of
CD19/IL-7Rα+ B cells is signiﬁcantly elevated in synovial tissue
from RA patients as compared with OA (ﬁgure 4B, p=0.03),
which also conﬁrms previous results.3 However, FACS analysis
of mixed synoviocytes revealed that the percentage of CD19 or
CD20 B cells expressing IL-7Rα is not different between OA
and RA (ﬁgure 4C). This result suggests that IL-7Rα+ B cells
Figure 4 B cells express IL-7 receptor α in synovial tissue from osteoarthritis (OA) and rheumatoid arthritis (RA) patients. (A) Representative
immunohistochemistry showing CD19 or IL-7Rα+ cells in synovial tissue as indicated at the bottom of each image. The right image represents a
merge of the two images to the left showing a double positive cell additionally stained with 40-6-diamidino-2-phenylindole (DAPI) for DNA staining
(blue colour). (B) Absolute number of IL-7Rα+/CD19 B cells in synovial tissue from RA (n=5) and OA (n=6) patients. Each dot represents results of
one patient with the mean number of IL-7Rα+/CD19 B cells averaged from counting 17 high power ﬁelds (400×). p Value was determined by
Mann–Whitney test. Results are presented as box plots, horizontal lines represent the median value. (C) FACS analysis of mixed synoviocytes. Each
dot represents the percentage of IL-7Rα+ and CD19 (left side), or IL-7Rα+ and CD20 (right side) cells isolated from synovial tissue of RA (CD19:
n=9; CD20: n=27) or OA (CD19: n=16; CD20: n=57) patients, respectively. Results are presented as box plots, horizontal lines represent the median
value. NS, not signiﬁcant in Mann–Whitney test. (D) Representative immunohistochemistry from RA tissue showing CD19, β2 adrenoceptor+, DAPI
or a merged image (Merge), as indicated.
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are not over-represented in RA synovium but might occur in
every inﬂammatory inﬁltrate.
Due to the interplay between β2AR and the IL-7/IL-7R
system evident in the CIA model, we conﬁrmed that this inter-
action might also take place in the human system by showing
that β2AR is expressed on synovial B cells from OA (data not
shown) and RA patients (ﬁgure 4D).
DISCUSSION
The IL-7/IL-7R system has been suggested to be involved in the
regulation of autoimmune inﬂammation.34 To our knowledge,
this is the ﬁrst report directly demonstrating a role for IL-7Rα
expressing B cells in CIA. Transfer of activated, IL-7 stimulated
B cells into CIA aggravates arthritis and increases production of
speciﬁc anti-CII antibodies, which might be one mechanism to
explain the propagation of arthritis, because it has been shown
before that anti-CII antibodies are correlated with disease activ-
ity and possess a direct pathogenic role.35 36
The prerequisite for B cells to react to IL-7 stimulation is the
re-expression of IL-7R on mature B cells. IL-7R is downregulated
at the pre-B cell stage and expression of the receptor on mature,
non-malignant B cells has only been reported in a few studies.3–5 It
had been suggested that CD40-induced activation in the germinal
centre promotes IL-7Rα re-expression which contributes to B cell
receptor editing by re-inducing recombination-activating-genes
proteins.4 We show that anti-CD40 independent of INFγ or IL-4
and lipopolysaccharide, a TLR4 ligand, increases IL-7Rα expres-
sion. Therefore, IL-7R re-expression can be induced by
T-dependent and T-independent activating stimuli and might be a
general feature of some activated B cells. Supporting this hypoth-
esis, OA and RA patients show the same percentage of IL-7R+ B
cells in synovial inﬁltrates, although B cell activation occurs in dif-
ferent ways in the two diseases.
IL-7R+ B cells might therefore be part of every inﬂammatory
inﬁltrate independent of the cause, thus, non-speciﬁc in RA.
Due to increased total cell number in RA as compared with OA
tissue, the absolute numbers of IL-7R-expressing B cells are sig-
niﬁcantly increased in RA as compared with OA, which conﬁrms
the results from a recent study.3 Together with the data pre-
sented above and supporting many other studies,3 6 10 17 18 30
the IL–7/IL-7R system might be a valuable drug target.
In addition, the present data show that treatment of CIA mice
with activated B cells exposed to norepinephrine during activa-
tion leads to more severe arthritis and increased anti-CII auto-
antibodies. It has been demonstrated in several reports before
that Th2-dependent antibody production is augmented follow-
ing β2AR stimulation on B cells (reviewed in21). This is the ﬁrst
report to show that Th1-dependent autoantibody production in
CIA is augmented by adrenergic stimulation of B cells.
However, because the activation of B cells in vitro is polyclonal,
the augmentation of the anti-CII response might not solely be
explained by increased production from B cells that were
exposed to norepinephrine in vitro but rather indirectly by pro-
moting autoreactive B cells in vivo.
When B cells were exposed to norepinephrine and subse-
quently stimulated with IL-7, a further increase in proinﬂamma-
tory action was expected. However, these B cells lose their
proinﬂammatory effect and show anti-inﬂammatory potential,
because they inhibit the proinﬂammatory capacity of norepineph-
rine treated B cells, and concomitantly show decreased ability to
stimulate anti-CII antibody production. The loss of proinﬂamma-
tory activity of IL-7 stimulated B cells goes along with a
decreased phosphorylation of STAT5 following IL-7 stimulation
in terbutaline-exposed cells. The β2AR stimulus interferes with
proper downstream IL7Rα-signalling because STAT5 total
protein content was unchanged in terbutaline-exposed B cells
(data not shown).
There is no known interaction between the β2AR and IL-7R
signalling pathways. One could speculate that negative regula-
tors of pSTAT5, like suppressor of cytokine signalling-1,37 or
CD4538 are upregulated by β2AR signalling, but this is yet to be
shown. Among others, phosphatidyl-inositol-3 kinase-
dependent,39 protein tyrosin kinase 2-dependent and mitogen
activated protein kinase p38-dependent pathways40 have been
suggested downstream of IL-7R in addition to STAT5 and might
also be candidates for mediators of this effect. Which one of
these pathways is used in norepinephrine pretreated B cells
needs to be determined in future studies.
Taken together, the present results demonstrate a proinﬂam-
matory role for IL-7R+ B cells in arthritis given the prerequisite
that B cells have not been activated in the presence of sympa-
thetic neurotransmitters. Usually, B cells in lymphoid organs are
exposed to sympathetic neurotransmitters,21 32 which would
render IL-7R expressing B cells inert to stimulation by IL-7, at
least in terms of STAT5-dependent mechanisms.
Vice versa, IL-7R+ B cells activated in the absence of sympa-
thetic neurotransmitters act proinﬂammatory in CIA, a situation
which occurs in inﬂamed synovial tissues in RA, where sympa-
thetic nerve ﬁbres are lost29 and ectopic germinal centres with
local B cell activation occur.17 41 Additionally, IL-7 is present in
inﬂamed RA tissue and synovial ﬂuid.11–15 Therefore, B cells
activated in inﬂamed joints in the absence of sympathetic neuro-
transmitters might propagate inﬂammation in response to IL-7.
Whether or not inhibition or modulation of IL-7 signalling via
adrenergic stimuli also occurs in T cells needs to be determined
(usually more IL-7R expression in T cells). In conclusion, the
present data support the hypothesis that the IL-7/IL-7R system
might be a valuable target in arthritis and underscores the
importance of the SNS in regulating inﬂammatory processes.
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